Job/Unit: O40088
/KAP1
Date: 09-04-14 17:41:45
Pages: 12
Arylethynyl-Substituted Tristriazolotriazines
CH2), 1.33 (m, 2 H, CH2), 1.11–1.25 (m, 4 H, CH2), 0.77–0.80 (m,
1421, 1382, 1354, 1255, 1115, 838 cm–1. FD-MS: m/z (%) = 731.2
3 H, CH3) ppm. 13C NMR (75 MHz, 25 °C, CDCl3): δ = 159.5 (C- (100) [M]+, 1464.6 (6) [M2]+. C47H62N4O3 (731.04): calcd. C 77.22,
4 PhЈ), 133.0, 131.9, 127.1 (C-2, C-3, C-5, C-6 Ph, C-2, C-6 PhЈ),
126.3 (C-1 Ph), 123.6 (C-4 Ph), 114.5 (C-3, C-5 PhЈ), 114.4 (C-1
PhЈ), 91.3 (C-2 In), 87.3 (C-1 In), 68.0 (OCH2), 31.6, 29.0, 25.6,
H 8.55, N 7.66; found C 76.97, H 8.34, N 7.47.
3,5-Bis[2-[3,4,5-tris(octyloxy)phenyl]ethynyl]phenyltetrazole (30):
According to procedure D, tetrazole 21 (152 mg, 0.5 mmol), alkyne
23 (535 mg, 1.1 mmol), Pd(PPh3)2Cl2 (7 mg), CuI (4 mg), and one
drop of trihexylamine in DMF/aq. K2CO3 (9:1, 50 mL) gave 30
(181 mg, 32%) as a colorless wax; m.p. 111 °C. Rf = 0.19 (toluene/
22.5 (CH ), 13.9 (CH ) ppm (C-5 Tet n.d.). IR (ATR): ν = 2920,
˜
2
3
2857.0 2210, 1603, 1513, 1470, 1431, 1385, 1353, 1294, 1250, 1162,
1110, 1061, 1035, 989, 836, 759 cm–1. FD-MS: m/z (%) = 346.3
(100) [M+]. C21H22N4O (364.41): calcd. C 72.81, H 6.40, N 16.17;
found C 72.46, H 6.68, N 15.76.
1
ethyl acetate 25:1). H NMR (400 MHz, 25 °C, CDCl3): δ = 7.91
(br s, 2 H, 2-H, 6-H Ph), 7.69 (m, 1 H, 4-H Ph), 6.68 (s, 4 H, 2-H,
3
3
5-{4-[2-(4-Didodecylaminophenyl)ethynyl]phenyl}-2H-tetrazole (27):
According to the general procedure D, tetrazole 20 (462 mg,
6-H PhЈ), 4.06 (t, J = 6.1 Hz, 4 H, OCH2), 3.92 (t, J = 6.1 Hz, 8
H, OCH2), 1.69–1.82 (m, 12 H, β-CH2), 1.20–1.49 (m, 60 H, CH2),
1.7 mmol), alkyne[47] 24 (817 mg, 1.8 mmol), Pd(PPh3)2Cl2 (28 mg), 0.83–0.87 (m, 18 H, CH3) ppm. 13C NMR (75 MHz, 25 °C,
CuI (15 mg), PPh3 (21 mg), and one drop of trihexylamine in piper-
idine (50 mL) gave 27 (625 mg, 62%) as a yellow solid. Rf = 0.28
(toluene/ethyl acetate 15:1). Compound 27 turned green within 1
CDCl3): δ = 155.3 (br, C-5 tet), 152.8 (C-3, C-5 PhЈ), 138.4 (C-4
PhЈ), 136.3 (C-3, C-5, Ph), 129.5 (C-1 Ph), 125.1 (C-2 Ph), 124.7
(C-4 Ph), 117.6 (C-1 PhЈ), 110.0 (C-2, PhЈ), 91.5, 86.3 (C-1, C-2
1
3
h. H NMR (400 MHz, CDCl3): δ = 8.04 (d, J = 8.3 Hz, 2 H, 2- In), 69.1, 74.2 (OCH2), 31.8, 30.1, 29.5, 29.3, 26.0, 22.0 (CH2 sup.),
3
3
H, 6-H Ph), 7.59 (d, J = 8.3 Hz, 2 H, 3-H, 5-H Ph), 7.35 (d, J =
14.1 (CH3 sup.) ppm. FD-MS: m/z (%) = 1116.9 (100) [M]+.
8.8 Hz, 2 H, 2-H, 6-H PhЈ), 6.56 (d, 3J = 8.8 Hz, 2 H, 3-H, 5-H
HRMS: calcd. for C71H111N4O6 [M + H]+ 1115.8504; found
PhЈ), 3.26 (m, 4 H, NCH2), 1.56 (m,4 H, β-CH2), 1.24–1.29 (m, 36 1115.8472.
H, CH ), 0.86 (m, 6 H, CH ) ppm. IR (KBr): ν = 2924, 2853, 2207,
˜
2
3
3,4,5-Tris(octyloxy)-ω,ω-dibromostyrene (23a): Zinc powder
(2.87 g, 44 mmol) and PPh3 (9.96 g, 44 mmol) were added to a solu-
tion of CBr4 (14.59 g, 44 mmol) in CH2Cl2 (150 mL), which was
degassed by purging with N2. At 0 °C, the mixture was sonicated
for 1 h (sonotrode, external cooling) and 3,4,5-tris(octyloxy)benz-
1603, 1560, 1521, 1466, 1400, 1369, 1197, 1133, 845, 812, 721 cm–1.
FD-MS: m/z (%) = 597.5 (100) [M]+.
5-{4-[2-[3,4,5-Tris(octyloxy)phenyl]ethynyl]phenyl}-2H-tetrazole
(24): According to procedure D, 20 (544 mg, 2 mmol), alkyne 23
(1.07 g, 2.2 mmol), Pd(PPh3)2Cl2 (14 mg), CuI (8 mg), PPh3 aldehyde[33] (5.40 g, 11 mmol) in anhydrous CH2Cl2 (50 mL) was
(10 mg), and one drop of trihexylamine in DMF/aq. K2CO3 (9:1,
added dropwise to the stirred suspension. Stirring was continued
70 mL) gave 24 (960 mg, 73%) as a colorless solid; m.p. 79 °C. Rf = for 15 min at 0 °C and 1.5 h at 25 °C. The liquid was decanted and
0.35 (SiO2, toluene/ethyl acetate 20:1). 1H NMR (400 MHz, 25 °C,
concentrated to 100 mL. Water (50 mL) and methanol (50 mL)
were added, and the aqueous layer was extracted with petroleum
ether (3ϫ75 mL). The combined organic solutions were washed
3
3
CDCl3): δ = 7.88 (d, J = 8.3 Hz, 2 H, 2-H, 6-H Ph), 7.50 (d, J =
3
8.3 Hz, 2 H,3-H, 5-H Ph), 6.66 (s, 2 H, 2-H, 6-H PhЈ), 4.05 (t, J
3
= 6.7 Hz, 2 H, OCH2), 3.87 (t, J = 6.5 Hz, 4 H,OCH2), 1.79–1.86 with brine (3ϫ50 mL) and dried (MgSO4). Column chromato-
(m, 2 H, β-CH2), 1.68–1.73 (m, 4 H,β-CH2), 1.25–1.48 (m, 30 H, graphy gave 23a as colorless oil (5.80 g, 82%). Rf = 0.39 (toluene/
1
CH2), 0.86 (m, 9 H, CH3) ppm. 13C NMR (75 MHz, 25 °C,
petroleum ether 1:3). H NMR (400 MHz, 25 °C, C6D6): δ = 7.26
3
CDCl3): δ = 153.0 (C-3, C-5 PhЈ), 138.1 (C-4 PhЈ), 132.6 (C3, C-5 (s, 1 H, 1-H vin), 6.72 (s, 2 H, 2-H, 6-H Ph), 4.19 (t, J = 6.4 Hz,
Ph), 127.2 (C-2, C-6 Ph), 126.3 (C-4 Ph), 123.3 (C-1 Ph), 117.8 2 H, OCH2), 3.76 (t, 3J = 6.4 Hz, 4 H, OCH2), 1.88 (m, 2 H, β-
(CC-1 PhЈ), 109.7 (C-2, C-6 PhЈ), 87.5 (C-1 In), 92.8 (C-2 In), 69.1, CH2), 1.55–1.70 (m, 6 H, CH2), 1.24–1.44 (m, 32 H, CH2), 0.89–
73.6 (OCH2), 32.0, 31.9, 30.3, 29.6, 29.4, 26.1, 22.7 (CH2, sup.), 0.93 (m, 9 H, CH3) ppm. 13C NMR (75 MHz, 25 °C, C6D6): δ =
14.1 (CH , sup.) ppm (C-5 Tet n.d.). IR (neat): ν = 2922, 2853, 153.3 (C-3, C-5 Ph), 139.6 (C-4 Ph), 137.3 (α-C vin), 130.0 (C-1
˜
3
2719, 2610, 2203, 1606, 1570, 1504, 1465, 1428, 1416, 1352, 1256,
1235, 1157, 1113, 1028, 993, 844, 750, 699 cm–1. FD-MS: m/z (%)
= 630.9 (100) [M]+, 1263.1 (10) [M2]+. HRMS: calcd. for
C39H58N4O3Na [M + Na]+ 653.4407, found 653.4387.
Ph), 107.5 (C-2, C-6 Ph), 88.2 (β-C vin), 69.0, 73.2 (OCH2), 32.0,
31.9, 30.7, 29.7, 29.5, 29.4, 26.3, 26.2, 22.8, (CH2 sup.), 14.1 (CH3
sup.) ppm. IR (film): ν = 2926, 2855, 1576, 1501, 1466, 1428, 1381,
˜
1331, 1239, 1115, 866, 836, 722 cm–1. FD-MS: m/z (%) = 646.9
(100) [M]+. C32H54Br2O3 (646.59): calcd. C 59.44, H 8.42; found C
59.35, H 8.36.
5-[4-(2-{4-[2-[3,4,5-Tris(octyloxy)phenyl]ethynyl]phenyl}ethynyl)-
phenyl]-2H-tetrazole (29): According to procedure D, diyne 25
(176 mg, 0.3 mmol), 20 (76 mg, 0.28 mmol), Pd(PPh3)2Cl2 (11 mg), [3,4,5-Tris(octyloxy)phenyl]acetylene (23): 3,4,5-Tris(octyloxy)-ω,ω-
CuI (6 mg), PPh3 (8 mg), and one drop of trihexylamine in DMF/ dibromstyrol (23a) (3.88 g, 6 mmol) was dissolved in anhydrous
aq. K2CO3 (9:1, 70 mL) gave 29 (133 mg, 65%) as a light yellow THF (220 mL) in a Schlenk flask, and the solution was deaerated
1
solid; m.p. 163 °C. Rf = 0.25 (toluene/ethyl acetate 15:1). H NMR
by three freeze–pump–thaw cycles. At –78 °C, nBuLi (2.5 m,
3
(400 MHz, 25 °C, CDCl3): δ = 7.97 (d, J = 8.2 Hz, 2 H, 2-H. 6-H 8.4 mL) was added, and the mixture was stirred (24 h at –78 °C
3
Ph), 7.53 (d, J = 8.2 Hz, 2 H, 3-H, 5-H Ph), 7.42 (s, 4 H, 2-H, 3-
and 24 h at r.t.). NH4Cl (satd. aq., 50 mL) was added, and the
organic layer was separated, washed with brine (3ϫ30 mL), dried
H, 5-H, 6-H PhЈ), 6.69 (s, 2 H, 2-H, 6-H, PhЈЈ), 4.06 (t, 3J = 6.7 Hz,
3
2 H, OCH2), 3.90 (t, J = 6.5 Hz, 4 H, OCH2), 1.70–1.80 (m, 6 H, (MgSO4), and concentrated. The residue was filtered through silica
β-CH2), 1.44 (m, 6 H, CH2) 1.27 (m, 24 H, CH2), 0.85–0.88 (m, 9
gel to give 23 as a colorless oil (2.69 g, 92%). 1H NMR (400 MHz,
H, CH3) ppm. 13C NMR (75 MHz, 25 °C, CDCl3): δ = 156.3 (C-5 25 °C, C6D6): δ = 6.87 (s, 2 H, 2-H, 6-H Ph), 4.15 (t, J = 6.4 Hz,
3
3
Tet), 152.9 (C-3, C-5 PhЈЈ), 138.0 (C-4 PhЈЈ), 132.2 (C-3, C-5 Ph), 2 H, 2 H, OCH2), 3.56 (t, J = 6 Hz, 4 H, 4 Hz, OCH2), 2.80 (s, 1
131.5, 131.6 (C-2, C-3, C-5, C-6 PhЈ), 127.4 (C-2, C-6 Ph), 126.2 H, Ph-CC-H), 1.86 (qui, 2 H, β-CH2), 1.57–1.60 (m, 8 H, CH2),
(C-4 Ph), 123.5 (C-1 Ph, C-4 PhЈ), 122.4 (C-1 PhЈ), 118.1 (C-1 1.24–1.32 (m, 26 H, CH2), 0.89–0.93 (m, 9 H, CH3) ppm. 13C NMR
PhЈЈ), 109.7 (C-2, C-6 PhЈЈ), 91.7 (C-1, C-2 InЈ, sup.), 90.2 (C-1
In), 88.1 (C-2 In), 69.0, 74.3 (OCH2), 31.9, 31.8, 30.3, 29.7, 29.5, (C-1 Ph), 111.0 (C-2, C-6 Ph), 84.3 (C-2 In), 76.1 (C-1 In), 68.7,
29.3, 29.2, 26.1, 22.7, 22.6, (CH2, sup.), 14.1 (CH3, sup.) ppm. IR 73.2 (OCH2), 32.0, 31.9, 30.7, 29.7, 29.5, 29.4, 26.3, 26.1, 22.8 (CH2
(75 MHz, 25 °C, C6D6): δ = 153.4 (C-3, C-5 Ph), 140.2 (C-4), 117.0
(KBr): ν = 3427, 2926, 2855, 2210, 1654, 1611, 1573, 1511, 1465, sup.), 14.1 (CH sup.) ppm. IR (film): ν = 3313, 2926, 2855, 2105,
˜
˜
3
Eur. J. Org. Chem. 0000, 0–0
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
9